Molecular structure of Sulfadiazine, CAS Number: 68-35-9
Sulfadiazine (CAS 68-35-9)
Alternate Names:
Pyrimal
Application:
Sulfadiazine is An antibacterial
CAS Number:
68-35-9
Purity:
99%
Molecular Weight:
250.28
Molecular Formula:
C10H10N4O2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Sulfadiazine is a sulfonamide antibiotic closely related to sulfanilamide. Although the exact mechanism of action of sulfadiazine remains incompletely elucidated, it is understood to impede bacterial growth through various means. Sulfadiazine interferes with the production of folic acid, a vital component for bacterial growth, thereby inhibiting their proliferation. Additionally, it disrupts the synthesis of proteins and other essential molecules, further impeding bacterial growth.
Sulfadiazine (CAS 68-35-9) References
- Myth: silver sulfadiazine is the best treatment for minor burns. | Chung, JY. and Herbert, ME. 2001. West J Med. 175: 205-6. PMID: 11527855
- Sulfadiazine-induced nephrolithiasis in children. | Catalano-Pons, C., et al. 2004. Pediatr Nephrol. 19: 928-31. PMID: 15206032
- The side effects of silver sulfadiazine. | Fuller, FW. 2009. J Burn Care Res. 30: 464-70. PMID: 19349889
- Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. | Simon, DI., et al. 1990. Arch Intern Med. 150: 2379-84. PMID: 2241449
- Sulfadiazine revisited. | Ventura, MG., et al. 1989. J Infect Dis. 160: 556-7. PMID: 2760508
- Experimental burns: Comparison between silver sulfadiazine and photobiomodulation. | Gomes, MT., et al. 2017. Rev Assoc Med Bras (1992). 63: 29-34. PMID: 28225874
- Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis. | Soares Rodrigues Costa, B., et al. 2020. Trop Med Int Health. 25: 364-372. PMID: 31802579
- Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases. | Yamamoto, K., et al. 2021. Pediatr Infect Dis J. 40: 324-326. PMID: 33181786
- A small-scale re-evaluation of the efficacy of silver sulfadiazine for burns. | Handayani, E. and Masithoh, RF. 2020. Br J Community Nurs. 25: S34-S38. PMID: 33300848
- Standard Selection Treatments with Sulfadiazine Limit Plasmodium yoelii Host-to-Vector Transmission. | Rios, KT., et al. 2022. mSphere. 7: e0010622. PMID: 35586987
- Sulfadiazine crystalluria in a patient with lupus nephritis. | Ruiz Álvarez, MJ., et al. 2022. Adv Lab Med. 3: 210-214. PMID: 37361864
- Landmark perspective: Sulfadiazine. | Petersdorf, RG. 1984. JAMA. 251: 1475-6. PMID: 6366264
- Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature. | Hoffmann, S. 1984. Scand J Plast Reconstr Surg. 18: 119-26. PMID: 6377481
Inhibitor of:
cSHMT, Pneumocystis carinii, and Toxoplasma gondii.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sulfadiazine, 25 g | sc-212969A | 25 g | $20.00 | |||
Sulfadiazine, 50 g | sc-212969 | 50 g | $32.00 | |||
| US: (Out of Stock: Availability March 27, 2026) | ||||||
Sulfadiazine, 100 g | sc-212969B | 100 g | $52.00 | |||
Sulfadiazine, 250 g | sc-212969C | 250 g | $94.00 | |||
Sulfadiazine, 1 kg | sc-212969D | 1 kg | $198.00 | |||